All sponsors

Xiamen Amoytop Biotech Co., Ltd.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-19
ACTIVE TRIALS5
PHASE 3 / 2-33
RECRUITING5
READOUTS ≤12 MONTHS0
Open Xiamen Amoytop Biotech Co., Ltd. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
Peginterferon α-2b injection
NCT06552429
P2RecruitingEssential Thrombocythemia272025-10-26
Inpegsomatropin Injection
NCT06927310
P3RecruitingIdiopathic Short Stature3002026-03
Inpegsomatropin Injection
NCT07551804
P2RecruitingAdult Growth Hormone Deficiency362027-12-31
Inpegsomatropin Injection
NCT07309562
P3RecruitingSmall for Gestational Age1412028-03
Inpegsomatropin-Injection
NCT07614152
P3RecruitingTurner Syndrome842028-03-30